Download Files:
GNF-8625 monopyridin-N-piperazine (hydrochloride)
$250 – $1,950
Products Details
Product Description
– GNF-8625 monopyridin-N-piperazine hydrochloride (TRKi-2), a TRK inhibitor, which is from the patent WO 2020038415 A1[1].
Web ID
– HY-131706A
Storage Temperature
– 4°C (Powder, stored under nitrogen)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C25H27ClFN7
References
– [1]By Liu, Jing, et al. Preparation of tropomyosin receptor kinase degradation compounds and methods of use. WO 2020038415 A1.
CAS Number
– 2412055-62-8
Molecular Weight
– 479.98
Compound Purity
– 99.74
SMILES
– FC1=CC([C@@H]2N(C3=NN4C(C=C3)=NC=C4C5=NC(N6CCNCC6)=CC=C5)CCC2)=CC=C1.[H]Cl
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 6.67 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Trk Receptor
Pathway
– Neuronal Signaling;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
